“ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY”. Student’s Journal of Health Research Africa, vol. 4, no. 12, Dec. 2023, p. 5, https://doi.org/10.51168/sjhrafrica.v4i12.865.